New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Psyence Biomedical Ltd.

PBM

Healthcare Biotechnology

2.97 0.11 +3.85%

After hours trading: 3.01, up 1.35%, last trade Fri 4:09pm Eastern.

Market cap
$10.9M
P/E
0.1×
Fwd P/E
—
Dividend yield
—
F-score
n/a
ROIC
—
Net debt / EBITDA
1.2×
Payout ratio
—
Older periods Mar '24 Sep '24 Mar '25 Sep '25
Current Ratio

+8 more quarters

0.09 0.64 11.04 8.09
Net Debt/EBITDA
— 1.70 — 4.78
Debt/Assets
0.00% 0.00% 0.00% 0.00%
Debt/Equity
— 0.00 0.00 0.00
Operating CF/Net income
0.00 — — —
Capex/Depreciation
(28.50) (3.56) — (0.08)
Interest Coverage
— (312.73) — (537.96)
Intangible Assets out of Total Assets
— 0.00 0.00 0.00
Share Based Compensation of Revenue
— 0.00% — 0.00%
Free Cash Flow per Share
0.00 — — —
Cash per Share
— 350.38 — 30.37
Shareholders Equity per Share
— (224.12) — 50.07
Interest Debt per Share
— 0.00 — 0.00
Book value per Share
— (224.12) — 50.07
Free Cash Flow
(2.95) (1.52) — (2.03)
Working Capital
(10.98) (1.27) 5.97 6.69
Capital Expenditures
(0.01) (0.01) — 0.00
Net Current Asset Value
(10.98) (1.27) 5.97 6.69
Other line items
Quick Ratio
0.07 0.59 10.61 7.82
Operating CF per Share
0.00 — — —
Capex per Share
0.00 — — —
Average Receivables
0.44 0.09 0.10 0.11
Average Assets
129.47 129.37 133.12 14.61
Average Common Equity
116.84 0.13 4.09 4.19
Capex to Sales
0.00 0.00 — 0.00

Fold the line items

Columns are period end dates